In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolatesJoseph Meletiadis, Spyros Pournaras, Aikaterini Michelaki et al.|International Journal of Antimicrobial Agents|2021Cited by 33